Virus Entry: How a Virus Picks a Lock and Breaks In

Two locks, one key: attachment and fusion

Entering a cell is a virus's hardest problem. It has no legs and no metabolism of its own, so it must find a specific molecule on a specific cell type, bind it tightly enough to hold on against thermal jostling and flowing fluid, and then force two lipid membranes — its own envelope and the cell's — to merge without either membrane simply resealing itself, which is what membranes do by default. Every enveloped virus solves this with the same two-stage logic: attachment, handled by one or more surface glycoproteins that recognise a host receptor, and fusion, handled by a dedicated fusion protein that drives the actual merger of the bilayers.

Attachment is a numbers game before it is a chemistry problem. A single spike-receptor bond has modest affinity, but a virion displays dozens to hundreds of copies of its attachment protein, and a cell surface displays a dense field of receptors. Multiple simultaneous low-affinity contacts add up to high avidity — the same trick your immune system's antibodies use — which is why virions cluster and "zipper" onto a membrane rather than snapping on with a single lock-and-key event. This diffusion-limited search is a genuinely stochastic process: a virion released into extracellular fluid performs something close to a random walk until it happens to collide with a permissive patch of membrane.

Receptor specificity is what draws the map of tropism

Which cells, tissues and species a virus can infect — its tropism — is decided almost entirely at this first step. Influenza haemagglutinin binds sialic acid, but avian strains prefer sialic acid linked α2,3 to galactose (abundant in bird gut and human lower-respiratory epithelium) while human-adapted strains prefer the α2,6 linkage that dominates the human upper airway; that single glycosidic-bond preference is a large part of why avian flu does not easily jump between people. HIV gp120 requires CD4 plus a chemokine co-receptor, CCR5 or CXCR4, which is why the CCR5-Δ32 deletion confers strong resistance. SARS-CoV-2 spike binds ACE2, and its priming by the host protease TMPRSS2 (or, in TMPRSS2-poor tissue, cathepsin L in the endosome) further narrows which cells actually get infected productively rather than merely bound. Rabies glycoprotein binds the nicotinic acetylcholine receptor at neuromuscular junctions, which is the molecular reason the virus travels along nerves rather than through blood.

Route one: fusion at the plasma membrane

Some viruses fuse directly at the cell surface, at neutral pH, the moment receptor binding triggers the right conformational change. Paramyxoviruses (measles, respiratory syncytial virus) and HIV work this way. Receptor engagement destabilises the fusion protein's metastable prefusion fold; it snaps into a hairpin postfusion state, and in doing so drags the viral and cell membranes together. This is the pH-independent route — no acidification is required, and it can happen in seconds at the cell surface, which also lets an infected cell fuse directly with its uninfected neighbours to form the syncytia characteristic of measles and RSV infection.

Route two: receptor-mediated endocytosis and the pH trigger

Influenza, and many others, instead let the cell do the work of internalising them. Receptor binding triggers clathrin-mediated endocytosis: the membrane patch under the virion invaginates, pinches off as a coated vesicle, sheds its clathrin coat, and becomes an early endosome. As the endosome matures into a late endosome, vacuolar ATPases pump protons in and the lumen acidifies from ~pH 7 to roughly pH 5–6. That drop is the trigger: haemagglutinin's fusion peptide, normally buried, is protonated, springs out and inserts into the endosomal membrane, and HA refolds from its metastable prefusion trimer into a much more stable postfusion hairpin. The energy released by that irreversible refolding is what physically pulls the two membranes together.

Fusion itself passes through a well-characterised intermediate called hemifusion: the two outer (contacting) lipid leaflets merge into a single stalk while the two inner leaflets remain separate, so lipids can mix but the aqueous contents of the two compartments still cannot. Only when a fusion pore nucleates through that hemifusion diaphragm — first as a small, flickering, reversible opening, then dilating irreversibly — does the viral genome gain a path into the cytoplasm. Class I fusion proteins (influenza HA, HIV gp41, coronavirus spike) are all α-helical and share this hairpin mechanism; class II (flaviviruses, alphaviruses) are β-sheet-rich and fold differently but reach the same hemifusion-then-pore endpoint; class III (rabies G, herpesvirus gB) share features of both. Different letters, same physics.

Why the endosomal route is a trap virus and host both exploit

Endocytosis buys a virus a second useful property beyond triggering fusion at the right moment: it hides the incoming particle from surface-patrolling antibodies and puts it in physical proximity to endosomal proteases that finish activating the fusion machinery. It also gives the host cell a chokepoint to defend — this is exactly why raising endosomal pH with drugs such as chloroquine, or blocking the priming protease with drugs such as camostat, can block entry of pH- or protease-dependent viruses, and why fusion inhibitors such as enfuvirtide (which locks HIV gp41 in its prefusion conformation) work by targeting this single mechanical step rather than the whole viral life cycle.

Frequently asked questions

Try it live

Everything above runs in your browser — open Virus Entry Mechanism and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.